Subba Rao Chaganti

      2019 Authors

      Addition by Subtraction

      Addition by Subtraction? Sounds paradoxical? Unbelievable? Consider what Lao Tzu, the great Chinese philosopher said 2,500 years ago. Here is the essence of what he said: To attain knowledge, add things everyday. To attain wisdom, subtract things everyday. Profit comes from what is there, and usefulness comes from what is not there.
      Subba Rao Chaganti -

      Recent Articles

      Cytonus expands its Scientific Advisory Board with mRNA expert Michael Houston, PhD

      Look Who’s On the Move!

      Switch Therapeutics Expands Leadership Team with Key Appointments

      Industry News

      CANbridge Pharmaceuticals CAN008 Phase 2 Trial for Treatment of Glioblastoma Multiforme (GBM) in China Reaches Full Enrollment

      Industry News

      Avacta Appoints Karen Harrison as Chief Operating Officer for Therapeutics Division

      Look Who’s On the Move!

      Newron Presents Six-Month Interim Data From the First 100 Patients Randomized in Study 014/015 at the 31st European Congress of Psychiatry

      Industry News

      Bristol Myers Squibb Receives European Commission Approval of Sotyktu (deucravacitinib), a Once-Daily Oral Treatment for Adults With Moderate-to-Severe Plaque Psoriasis

      Editor´s Pick

      Silence Therapeutics Appoints Dr. Steven Romano as Incoming Chief Medical Officer and Head of Research and Development

      Look Who’s On the Move!

      Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases

      Industry News

      Prilenia Achieves Last Patient Last Visit in Phase 3 PROOF-HD Clinical Study for Huntington’s Disease

      Industry News

      Simulations Plus Enters New Strategic Collaboration to Discover Anticancer Therapies Through Its AI-Driven Drug Design Technology

      Industry News

      Virpax Pharmaceuticals Announces Appointment of Barbara A. Ruskin, Ph.D, J.D. to the Board of Directors

      Look Who’s On the Move!

      Andrew Miller Joins Elucid as Chief Technology Officer

      Look Who’s On the Move!

      OncoVerity, Inc. Announces Exclusive Worldwide Licensing Rights to Cusatuzumab and Appoints Max Colao as Chief Executive Officer

      Regulatory Affairs

      ANANDA Scientific Announces First Patient Enrolled in FDA-approved Clinical Trial Evaluating a Potential New Treatment for Social Anxiety Disorder (SAD)

      Regulatory Affairs

      Direct Biologics Announces First Patient Dosed with ExoFlo™ in a Phase 1 Clinical Trial for Medically Refractory Ulcerative Colitis

      Industry News

      2021 © Copyright - TPMG

      Get a free copy of "Cracking the Generics Code"

      Looks like you are using an ad-blocking browser extension. We request you to whitelist our website on the ad-blocking extension and refresh your browser to view the content.